The effectiveness of the fluoroquinolone ciprofloxacin is dependent on
stromal drug concentrations which exceed the minimum inhibitory conce
ntration(90) (MIC(90)). The purpose of this study is to compare cornea
l tissue ciprofloxacin levels in patients exposed to three ciprofloxac
in dosing regimens before undergoing penetrating keratoplasty. Thirty-
one patients were assigned to one of three treatment groups. Group 1 f
ollowed a ciprofloxacin dosing regimen compatible with home use [two d
rops of 0.3% ciprofloxacin (Ciloxan; Alcon Laboratories, Fort Worth, T
X, U.S.A.) every 4 h over a 24-h period]. Groups 2 and 3 followed a mo
re tightly controlled dosing regimen designed for a health-care settin
g (two drops of Ciloxan applied by a trained professional every 15 min
over a 4-h period). In groups 1 and 2, corneal epithelium was left in
tact, whereas in group 3 corneas were abraded. Corneal tissue samples
were surgically obtained. Excised buttons were frozen and Ciloxan conc
entration determined by high-pressure liquid chromatography. Ciloxan c
orneal tissue concentrations (mean +/- SD) were 8.82 +/- 8.24 mu g/g t
issue in group 1, 166.20 +/- 336.94 mu g/g tissue in group 2, and 938.
30 +/- 1,081.51 mu g/g tissue in group 3. Ciloxan penetration can be i
mproved by administering the drug in a controlled setting at 15-min in
tervals over a 4-h period. Individual Ciloxan concentrations exceeded
the MIC(90) for most key ocular pathogens despite wide variability in
all experimental groups.